142 related articles for article (PubMed ID: 1189353)
1. [Potentiation of the antitumor action of cyclophosphamide with a change in the cell population makeup and an increase in cellular permeability].
Frankfurt OS
Vopr Onkol; 1975; 21(10):63-7. PubMed ID: 1189353
[TBL] [Abstract][Full Text] [Related]
2. [Effect of the combined use of pyrogenal and cyclophosphane on experimental tumors].
Kolosov AI; Krupkin RG
Vopr Onkol; 1977; 23(10):90-2. PubMed ID: 595532
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy of tumors (an experimental study)].
Stukov AN
Vopr Onkol; 1975; 21(3):65-9. PubMed ID: 805499
[TBL] [Abstract][Full Text] [Related]
4. Uridine enhances the chemotherapeutic action of the 4'-demethylepipodophyllotoxin-thenylidene-glucoside (VM 26)-cyclophosphamide combination on i.m. implanted Ehrlich carcinoma.
Osswald H
Arzneimittelforschung; 1978; 28(3):387-8. PubMed ID: 580745
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the antitumor activity of 5-fluorouracil by drug combinations.
Frankfurt OS
Cancer Res; 1973 May; 33(5):1043-7. PubMed ID: 4267349
[No Abstract] [Full Text] [Related]
6. [Potentiation of the antitumor action of alkylating compounds by amphotericin B].
Iaremenko KV; Eremeeva AA; Tereshin IM
Antibiotiki; 1977; 22(2):153-8. PubMed ID: 404957
[No Abstract] [Full Text] [Related]
7. An experimental model comparing the antineoplastic and the immunosuppressive effects of some cytostatics.
Ghyka G; Haraga L
Arch Roum Pathol Exp Microbiol; 1989; 48(1):33-45. PubMed ID: 2802968
[TBL] [Abstract][Full Text] [Related]
8. [Influence of interferon on the toxic effect and antitumor activity of vinblastine in the combined therapy of metastatic Lewis carcinoma].
Vorontsova AL; Kudriavets IuI; Fadeev VA
Eksp Onkol; 1984; 6(6):54-7. PubMed ID: 6084588
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumor cells treated with cyclophosphamide in vivo.
Mourelatos D; Dozi-Vassiliades J; Kotsis A; Gourtsas C
Cancer Res; 1988 Mar; 48(5):1129-31. PubMed ID: 3342394
[TBL] [Abstract][Full Text] [Related]
10. [Experiment to potentiate the effect of cyclophosphamide combined with tempidon and caffeine in leukemia L1210 and Lewis hepatic carcinoma].
Stoichkov I; Milushev A; Todorov D
Eksp Med Morfol; 1978; 17(1):9-14. PubMed ID: 639751
[TBL] [Abstract][Full Text] [Related]
11. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice].
Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN
Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206
[TBL] [Abstract][Full Text] [Related]
12. [Cell division reaction in mouse Ehrlich ascites tumor in response to adrenaline].
Romanov IuA; Biks KA
Biull Eksp Biol Med; 1981; 91(1):69-71. PubMed ID: 7214012
[TBL] [Abstract][Full Text] [Related]
13. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of antitumor activity of an antibody-interleukin 2 immunocytokine with chemotherapeutic agents.
Holden SA; Lan Y; Pardo AM; Wesolowski JS; Gillies SD
Clin Cancer Res; 2001 Sep; 7(9):2862-9. PubMed ID: 11555604
[TBL] [Abstract][Full Text] [Related]
15. Chemoprotection and enhancement of cancer chemotherapeutic efficacy of cyclophosphamide in mice bearing Ehrlich ascites carcinoma by diphenylmethyl selenocyanate.
Chakraborty P; Sk UH; Bhattacharya S
Cancer Chemother Pharmacol; 2009 Oct; 64(5):971-80. PubMed ID: 19221751
[TBL] [Abstract][Full Text] [Related]
16. [Enhancement by metronidazole of the antitumor effect of cyclophosphane].
Riabchenko NI; Smoryzanova OA; Proskuriakov SIa; Dedenkov AN
Radiobiologiia; 1986; 26(5):661-3. PubMed ID: 3774977
[TBL] [Abstract][Full Text] [Related]
17. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of cyclophosphamide-treated tumor cells.
Kawalec M; Skórski T; Hoser G
Arch Immunol Ther Exp (Warsz); 1988; 36(3):345-50. PubMed ID: 3250356
[TBL] [Abstract][Full Text] [Related]
19. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Milas L; Ito H; Hunter N
Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
[TBL] [Abstract][Full Text] [Related]
20. [Action of the chalone from Ehrlich's ascites, tumor in mice on the mitotic activity in this tumor after single and double administrations].
Romanov IuA; Semenova MV
Biull Eksp Biol Med; 1980 Feb; 89(2):189-91. PubMed ID: 6445214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
